Akademik Veri Yönetim Sistemi
Cerrahpasa Tip Dergisi, cilt.27, sa.4, ss.225-229, 1996 (Scopus)
Background. Varicella in a self-limited disease and rarely complicated in otherwise healthy children. On the other hand the course may be severe in adults and immunocompromised patients. Live attenuated varicella vaccine was licensed in USA on March 17, 1995 for use in individuals 12 months of age and older who did not develop varicella. It has been shown to be immunogenic and adverse effects were acceptable. There is some concern that if extensive immunization with varicella vaccine is achieved, the infection might be seen more frequently in adulthood, which has more severe course. The duration of immunity the booster effect of wild type varicella is a question of consideration. More data is needed before recommending routine varicella vaccination.